High Purity Kanamycin Sulfate Powder: A Potent Antibiotic API for Diverse Pharmaceutical Applications
Discover the power of Kanamycin Sulfate, a >99% pure antibiotic powder crucial for combating Gram-negative bacteria and tuberculosis. Trust our reliable supply for your pharmaceutical needs.
Get a Quote & SampleProduct Core Value
Kanamycin Sulfate
As a leading supplier in China, we provide high-purity Kanamycin Sulfate (>99%) powder, a vital Active Pharmaceutical Ingredient (API). Our product is your reliable source for effective treatment against severe Gram-negative bacterial infections and drug-resistant tuberculosis. We are a trusted manufacturer in China, committed to quality and purity.
- Experience the efficacy of Kanamycin Sulfate powder in treating Gram-negative bacteria, a key application for this potent antibiotic.
- Secure your supply of high purity antibiotic API from a reliable manufacturer in China to meet stringent pharmaceutical standards.
- Combat drug resistant tuberculosis treatment with our Kanamycin Sulfate, a crucial component in second-line therapy schemes.
- Explore our offerings as a pharmaceutical intermediate supplier, providing essential materials for drug development and production.
Product Advantages
Exceptional Purity
Our Kanamycin Sulfate boasts over 99% purity, ensuring efficacy and safety for pharmaceutical applications, crucial for any pharmaceutical intermediate supplier.
Broad-Spectrum Efficacy
Effective against a wide range of bacteria, including Gram-negative strains and Mycobacterium tuberculosis, making it a versatile antibiotic API.
Quality Certifications
Compliant with GMP, HSE, ISO 9001, USP, and BP standards, guaranteeing the quality and reliability of our Kanamycin Sulfate powder.
Key Applications
Antibacterial Agent
Utilize this Kanamycin Sulfate powder as a powerful antibacterial agent to combat infections caused by Gram-negative bacteria, a core use for a high purity antibiotic API.
Tuberculosis Treatment
Essential for the drug resistant tuberculosis treatment, serving as a second-line drug in WHO schemes, highlighting its importance as a pharmaceutical intermediate.
Severe Infections Management
Effective in treating severe Gram-negative bacterial infections like sepsis and abdominal infections when other treatments fail, underscoring its value as an API.
Local Medication
Can be formulated into eye preparations for bacterial keratitis, demonstrating its versatility beyond systemic treatment options.